BeyondBio
Daejeon
About BeyondBio
BeyondBio is a biotechnology firm that specializes in the research and development of synthetic pharmaceutical drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.6M
- Last round: Series Unknown (Aug 2021)
- Website: beyondbio.co.kr
- Phone: +82 42 716 0020
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/beyondbio-38614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.